Drug Profile
TDZD 8
Alternative Names: TDZD-8Latest Information Update: 25 Aug 2023
Price :
$50
*
At a glance
- Originator University of Rochester
- Developer Panther Biotechnology; University of Rochester
- Class Anti-ischaemics; Antineoplastics; Neuroprotectants; Small molecules; Thiazolidines
- Mechanism of Action Apoptosis stimulants; Protein kinase inhibitors; Stem cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Leukaemia